发明名称 |
Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
摘要 |
<p>(R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide has been found to have precognitive effects in humans at unexpectedly low doses. Thus, (R) -7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof can be used at unexpectedly low doses improve cognition.</p> |
申请公布号 |
EP2540297(B1) |
申请公布日期 |
2015.04.08 |
申请号 |
EP20120185913 |
申请日期 |
2009.11.19 |
申请人 |
FORUM PHARMACEUTICALS INC. |
发明人 |
KOENIG, GERHARD;CHESWORTH, RICHARD;SHAPIRO, GIDEON |
分类号 |
A61K31/439;A61P25/00 |
主分类号 |
A61K31/439 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|